Neither is dramatically easier on side effects
A: Slightly more effective (15-22% vs 15-17% weight loss)
The following symptoms warrant prompt medical attention and patients should contact their GP or seek urgent care if they experience: Severe or persistent abdominal pain , which may indicate pancreatitis a recognised risk with GLP-1-containing therapies [13] Jaundice, right upper quadrant pain, or fever , which may suggest gallbladder disease Signs of dehydration or reduced kidney function , such as dizziness, markedly reduced urine output, or confusion, particularly if vomiting or diarrhoea is prolonged Visual changes , particularly in individuals with pre-existing diabetic retinopathy Patients taking retatrutide alongside insulin or a sulfonylurea should be aware of an increased risk of hypoglycaemia (low blood sugar)
Chronic pain often stems from inflammation and oxidative damage to tissues
Increased mucus can also be a sign of illness, especially if inflammation occurs and the mucous membrane breaks down
Tirzepatide is a dual agonist, meaning it mimics two hormones: GLP-1 and GIP